Health
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2 – News-Medical.Net
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers…
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
The current coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2, has exposed earnest weaknesses…
-
General14 hours ago‘We are here for you’: PM to bring help to flood zones
-
General12 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News20 hours agoStudents say new facility would be better in rural areas of Queensland
-
General8 hours agoInternal Revenue Service starts cutting 20,000 workers